SCHEMBL5929017

SCHEMBL5929017

CCc1cccc(CC)c1-c1nc(Br)c(CN2CCCCC2C2=COC=C(C3=CC=CCC3)O2)n1CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929067 0.87 GAA (0.32) —
SCHEMBL5929300 0.73 KDM4E (0.41) —
SCHEMBL5929012 0.72 POLB (0.38) —
SCHEMBL5928890 0.66 KDM4E (0.32) —
SCHEMBL5929178 0.66 OPRK1 (0.39) —
SCHEMBL5928992 0.66 CYP3A4 (0.36) —
SCHEMBL5929363 0.66 KMT2A (0.39) —
SCHEMBL5929124 0.65 BCHE (0.37) —
SCHEMBL5929189 0.65 KMT2A (0.36) —
SCHEMBL5928973 0.65 KMT2A (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed
WO-2005007087-A2 SUBSTITUTED (HETEROCYCLOALKYL)METHYL AZOLE DERIVATIVES AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2005-01-27 — — WO disclosed
Send feedback